Xanodyne Pharmaceuticals, Inc. Company Profile | Company Information

milicinodijoo1981.blogspot.com
Xanodyne Pharmaceuticals is a privately-owned company backedr by some of the foremost privatd capital investorsin healthcare. Although a youn g company, Xanodyne has already established itselfd as a strong and competengt entity in the branded specialtuypharmaceutical industry. Xanodyne Pharmacal, Inc. was founded in July of 2001 in the Greate Cincinnati area byRoger Griggs, Chairmam of Union Springs LLC, a privatde equity group that focuses exclusively on investments in the life sciencexs sector, and Dr. Gilberft Gonzales, a neurologist and pain management Sinceits inception, Xanodyne has set a rapif pace of growth, development and acquisitions.
In 2001, it acquired Drug Enhancement Company of Americ aLLC (DECA), a privately held pharmaceutical productg development company. This acquisition not only increased the numberof near-termj pharmaceutical development projects, which complemented Xanodyne's strategic direction, but it also broughyt expertise and talented employeesz from DECA to Xanodyne. In earl 2004, Xanodyne Pharmacal, Inc. merged with Indianapolis-based Integritty Pharmaceuticals, Inc., (a womens health specialty company) with the newlyy merged company being renamedXanodyne Pharmaceuticals, Inc. In July of Xanodyne completed a transaction to acquirre most of the assetsof aaiPharma's pharmaceuticals division.
The deal value was in excessd of $200 million in cash...